2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

August 20, 2019 e333 *Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. †ACC/AHA Representative. ‡STS Representative. §HRS Representative. ‖PACES Representative. ¶ACC/AHA Task Force on Clinical Practice Guidelines Liaison. #AATS Representative. **Dr. Pellegrini contributed to this article in her personal capacity. The views expressed are her own and do not necessarily represent the views of the US Department of Veterans Affairs or the US government. ††ACC/AHA Performance Measures Representative. WRITING COMMITTEE MEMBERS* Fred M. Kusumoto, MD, FACC, FAHA, FHRS, Chair Mark H. Schoenfeld, MD, FACC, FAHA, FHRS, Vice Chair Coletta Barrett, RN, FAHA† James R. Edgerton, MD, FACC, FHRS‡ Kenneth A. Ellenbogen, MD, FACC, FAHA, FHRS*† Michael R. Gold, MD, PhD, FACC*§ Nora F. Goldschlager, MD, FACC, FAHA, FHRS† Robert M. Hamilton, MD‖ José A. Joglar, MD, FACC, FAHA, FHRS¶ Robert J. Kim, MD† Richard Lee, MD, MBA# Joseph E. Marine, MD, MBA, FACC, FHRS§ Christopher J. McLeod, MB, ChB, PhD, FACC, FAHA, FHRS† Keith R. Oken, MD, FACC† Kristen K. Patton, MD, FACC, FAHA, FHRS† Cara N. Pellegrini, MD, FHRS*§** Kimberly A. Selzman, MD, MPH, FACC, FHRS† Annemarie Thompson, MD† Paul D. Varosy, MD, FACC, FAHA, FHRS††